MedPath

Predicting Severe Outcomes Among Children Hospitalized With Community-acquired Pneumonia

Completed
Conditions
Child
Pneumonia
Prognosis
Registration Number
NCT05744609
Lead Sponsor
Children's Hospital of Fudan University
Brief Summary

In this study, investigators aimed to develop and validate a risk score to predict severe outcomes (e.g., mortality and ICU admission) in children who were admitted to the Children's Hospital of Fudan University between 2017 and 2022 due to community-acquired pneumonia (CAP). The objectives were as follows.

1. Develop a risk prediction model based on demographic, comorbidity, clinical characteristics, laboratory data, and chest radiographic reports to predict severe outcomes among children hospitalized with CAP;

2. Develop a risk scoring system and determine the cut-off point;

3. Externally validate the easy-to-use risk score.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6000
Inclusion Criteria
  1. Aged between 29 days and 18 years old;
  2. Admitted to hospital with signs or symptoms of acute infection (eg, fever) and acute respiratory illness (eg, cough), and radiographic evidence of pneumonia.
Exclusion Criteria
  1. Pneumonia developed 48 hours after admission or intubation;
  2. Chronic pneumonia, tuberculosis, tracheobronchial foreign bodies, aspiration pneumonia, parasitic lung disease, and diffuse pulmonary interstitial/parenchyma disease.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
in-hospital mortalityfrom admission to discharge, an average of 7 days

in-hospital mortality among children hospitalized with CAP

Secondary Outcome Measures
NameTimeMethod
admission to ICUfrom admission to discharge, an average of 7 days

admission to a intensive care unit for over 24 hours

septic shockfrom admission to discharge, an average of 7 days

occurrence of septic shock during admission

treatment for severe pneumoniafrom admission to discharge, an average of 7 days

vasoactive agents, positive-pressure ventilation or chest drainage, or extracorporeal membrane oxygenation

Trial Locations

Locations (1)

Children's Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath